Background Platelet-derived lyophilized growth factors (L-GF) uses a standardized number of allogenic pathogen-free platelets instead of autologous platelets used in PRP as a source of growth factors. This study aimed to evaluate the efficacy of L-GF injection versus placebo in the treatment of subacromial impingement (SIS). Methods The current randomized double-blind placebo-controlled study included sixty patients (40 females and 20 males, aged between 24-75 years) diagnosed with SIS (both clinically and sonographically). Patients were randomly assigned to two equal groups. Group 1 received subacromial saline injection, and group 2 received L-GF injection. Both groups were injected under ultrasound guidance. Clinical examination, Visual analogue scale (VAS) of pain, Shoulder Pain and Disability Index (SPADI), and shoulder ultrasound were performed before and at the 8th week after injection. Results Follow-up assessment showed statistically significant improvement in the L-GF group with regard to active flexion, active and passive internal rotation and extension, SPADI-Disability scale, VAS of pain and thickness of the supraspinatus tendon by US. Concerning painful arc, regression analysis showed that the placebo group was approximately 30 times more likely than the L-GF group to experience painful arc at follow-up. Both groups showed statistically significant improvement regarding the SPADI-Pain scale and SPADI-Total as well as passive flexion and abduction (still the mean value of abduction was significantly higher in the L-GF group). Conclusions L-GF injection resulted in clinically significant reductions in pain and functional disability outcomes in patients with SIS. An objective significant reduction in the thickness of the supraspinatus tendon, measured by ultrasound, in the L-GF group hopefully encourages proper healing and functioning in SIS. Trial registration: The identification number is NCT04330027, date of first registration (01/04/2020). Unique on 21/11/2019, Protocol ID: 0106178,
ObjectiveEvaluate efficacy of platelet-derived lyophilized growth factors (L-GF) injection versus placebo in treatment of subacromial impingement (SIS).MethodsSixty patients with SIS (clinically and sonographically) were included in this randomized double blind placebo controlled study. Patients were randomly divided to receive either saline (group 1) or L-GF (group 2) injection, under US-guidance. Clinical examination, Visual analogue scale of pain, Shoulder Pain and Disability Index (SPADI), and shoulder ultrasound were done before and at 8th week after injection. ResultsFollow up assessment showed statistically significant improvement in L-GF group as regards active flexion & active and passive internal rotation and extension, SPADI-Disability scale, VAS of pain as well as thickness of the supraspinatus tendon by US. Concerning painful arc, regression analysis has shown that placebo group is about 30 times more than the L-GF group to get painful arc at follow up. On the other hand, both groups showed statistically significant improvement regarding SPADI-Pain scale and SPADI-Total as well as passive flexion & abduction (still mean value of abduction was significantly higher in LG-F group). ConclusionsL-GF injection in patients with SIS has resulted in significant improvement as regards pain and disability according to the improvement in shoulder range of movement, painful arc sign, VAS, SPADI, as well as significant reduction in the thickness of the supraspinatus tendon as measured by ultrasound compared to the saline group. Trial registration: Identification number is NCT04330027, date of first registration (01/04/2020)Unique on 21/11/ 2019, Protocol ID: 0106178,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.